HERNDON CAPITAL MANAGEMENT LLC - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 309 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
HERNDON CAPITAL MANAGEMENT LLC ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$2,280,323,000
+14.6%
14,595
-9.5%
0.03%
+20.0%
Q2 2014$1,989,635,000
+12.8%
16,130
-5.3%
0.02%
+8.7%
Q1 2014$1,764,271,000
+14.0%
17,028
-1.1%
0.02%
+15.0%
Q4 2013$1,547,957,000
+2.9%
17,211
-23.4%
0.02%0.0%
Q3 2013$1,503,662,000
-98.2%
22,483
-98.2%
0.02%
-98.4%
Q2 2013$84,967,823,0001,284,4721.27%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Verition Fund Management LLC 2,787,800$481,760,00055.98%
Brenner West Capital Advisors 1,800,000$311,058,00028.01%
FNY Managed Accounts LLC 180,357$31,167,493,00025.70%
Twin Securities, Inc. 1,189,192$205,505,00024.16%
FIRST NEW YORK SECURITIES LLC /NY 98,099$16,952,488,00016.70%
HARVEST MANAGEMENT LLC 77,500$13,393,00014.40%
Tyrus Capital S.A.M. 687,800$118,859,00013.24%
BARDIN HILL MANAGEMENT PARTNERS LP 472,550$81,661,00011.65%
ARGENTIERE CAPITAL AG 151,500$26,181,00010.81%
Sachem Head Capital 725,000$125,425,0008.31%
View complete list of SALIX PHARMACEUTICALS INC shareholders